Neuroprotective approaches: before and after delivery

Lina F Chalak1, Dwight J Rouse

  • 1Division of Neonatal-Perinatal Medicine, Department of Pediatrics, The University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390-9063, USA. lina.chalak@utsouthwestern.edu

Clinics in Perinatology
|September 6, 2011
PubMed

Insights

Preterm infants face high cerebral palsy risks. This review explores antenatal and postnatal neuroprotective strategies, including magnesium sulfate, to mitigate these risks.

Area of Science:

  • Neonatal neurology
  • Developmental pediatrics

Background:

  • Preterm birth is a significant risk factor for cerebral palsy.
  • The risk of cerebral palsy increases as gestational age at birth decreases.
  • Prematurity substantially contributes to the global burden of cerebral palsy.

Purpose of the Study:

  • To review and discuss antenatal and postnatal neuroprotective strategies for preterm infants.
  • To identify interventions targeting risk factors for cerebral palsy in this vulnerable population.

Main Methods:

  • Literature review of antenatal and postnatal neuroprotective approaches.
  • Discussion of specific interventions, including magnesium sulfate.
  • Analysis of risk factors associated with cerebral palsy in preterm infants.

Main Results:

  • Multiple risk factors contribute to cerebral palsy in preterm infants.
  • Antenatal and postnatal interventions show potential for neuroprotection.
  • Magnesium sulfate is highlighted as a potential neuroprotective agent.

Conclusions:

  • Targeted neuroprotective strategies are crucial for preterm infants at risk of cerebral palsy.
  • A combination of antenatal and postnatal approaches may offer the most benefit.
  • Further research into optimizing neuroprotective interventions is warranted.

Related Concept Videos